血清Ｎ末端Ｂ型利钠肽在识别川崎病冠状动脉损伤中的研究进展-《天津医科大学学报》

参考文献/References:

[1] Mccrindle B W，Rowley A H，Newburger J W，et al. Diagnosis，treatment，and long-term management of kawasaki disease：a scientific statement for health professionals from the American Heart Association[J]. Circulation，2017，135（17）:e927
[2] Yukie O，Yamada F，Kishimoto T，et al. Epidemiologic features of Kawasaki disease：winter versus summer[J]. Pediatr Int，2017， 59（7）:821
[3] De Graeff N，Groot N，Ozen S，et al. European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative[J]. Rheumatology，2019，58（4）:672
[4] Nakamura Y. Kawasaki disease：epidemiology and the lessons from it[J]. Int J Rheum Dis，2018，21（1）:16
[5] Salgado A P，Ashouri N，Berry E K，et al. High risk of coronary artery aneurysms in infants younger than 6 months of age with kawasaki disease[J]. J Pediatr，2017，185:112
[6] 王亚洲，黄芩，李小明，等. 川崎病冠状动脉损害与发热持续时间的相关性[J]. 昆明医科大学学报，2020，41（2）:87
[7] Chang L S，Hus Y W，Lu C C，et al. CYP2E1 gene polymorphisms related to the formation of coronary artery lesions in kawasaki disease[J]. Pediatr Infect Dis J，2017，36（11）:1039
[8] Zha L T，Li S T，Xin L，et al. Association of miR-146a gene polymorphism at loci rs2910164 G/C，rs57095329 A/G，and rs6864584 T/C with susceptibility to kawasaki disease in Chinese children[J]. Pediatr Cardiol，2019，40（3）:504
[9] Bold A D，Borenstein H B，Veress A T，et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats[J]. Life Sci，1981，28（1）:89
[10] Sudoh T，Kangawa K，Minamino N，et al. A new natriuretic peptide in porcine brain[J]. Nature，1988，332（6159）:78
[11] Mckie P M，Burnett J C Jr. NT-proBNP the Gold standard biomarker in heart failure[J]. J Am Coll Cardiol，2016，66（22）:2437
[12] Del Principe D，Pietraforte D，Gambardella L，et al. Pathogenetic determinants in Kawasaki disease：the haematological point of view[J]. J Cell Mol Med，2017，21（4）:632
[13] Kenneth K M，Ogawa T，Adolfo J B. Selective upregulation of cardiac brain natriuretic peptide at the transcriptional and translational levels by pro-inflammatory cytokines and by conditioned medium derived from mixed lymphocyte reactions via p38 MAP kinase[J]. J Mol Cell Cardiol，2004，36（4）:505
[14] Yanagisawa D，Ayusawa M，Kato M，et al. Factors affecting N-terminal pro-brain natriuretic peptide elevation in the acute phase of Kawasaki disease[J]. Pediatr Int，2016，58（11）：1105
[15] Mueller K，Thiel F，Beutner F，et al. Brain damage with heart failure：cardiac biomarker alterations and gray matter decline[J]. Circ Res，2020，126（6）：750
[16] Mcneal-Davidson A，Fournier A，Spigelblatt L A，et al. Value of amino-terminal pro B-natriuretic peptide in diagnosing Kawasaki disease[J]. Pediatr Int，2012，54（5）：627
[17] Matsuura H，Ishikita T，Yamamoto S，et al. Gallium-67 myocardial imaging for the detection of myocarditis in the acute phase of Kawasaki disease （mucocutaneous lymph node syndrome）： the usefulness of single photon emission computed tomography[J]. Heart，1987，58（4）：385
[18] Harada M，Yokouchi Y，Oharaseki T，et al. Histopathological characteristics of myocarditis in acute-phase Kawasaki disease[J]. Histopathology，2012，61（6）：1156
[19] Kang J H，Lee D S，Seo I A，et al. Early detection of kawasaki disease in infants[J]. Circulation，2015，131（2）：510
[20] Kato M，Ayusawa M，Watanabe H，et al. Cardiac function on 3-D speckle tracking imaging and cytokines in Kawasaki disease[J]. Pediatr Int，2018，60（4）：342
[21] Song H B，Zhang Y D，Dong Q W，et al. Significance of serum NT-proBNP and endogenous H2S for predicting coronary artery lesions in pediatric kawasaki disease[J]. J Coll Physicians Surg Pak，2020， 30（1）:37
[22] 杨芳，王晓莉，欧宓，等.N端脑钠肽前体与超声心动图对川崎病的早期诊断对比研究[J].中华实用儿科临床杂志，2019，34（23）：1803
[23] 刘力. 川崎病休克综合征的早期识别与处理[J]. 中国小儿急救医学，2020，27（5）：346
[24] Kim M K，Song M S，Kim G B. Factors predicting resistance to intravenous immunoglobulin treatment and coronary artery lesion in patients with kawasaki disease：analysis of the korean nationwide multicenter survey from 2012 to 2014[J]. Korean Circ J，2018，48（1）:71
[25] Nir A，Nasser N. Clinical value of NT-ProBNP and BNP in pediatric cardiology[J]. J Card Fail，2005，11（5，S）:S76
[26] Nir A，Lindinger A，Rauh M，et al. NT-Pro-B-type natriuretic peptide in infants and children：reference values based on combined data from four studies[J]. Pediatr Cardiol，2009，30（1）:3
[27] Kwon H，Lee J H，Jung J Y，et al. N-terminal pro-brain natriuretic peptide can be an adjunctive diagnostic marker of hyper-acute phase of Kawasaki disease[J]. Eur J Pediatr，2016，175（12）:1997
[28] Reddy M，Singh S，Rawat A，et al. Pro-brain natriuretic peptide （ProBNP） levels in North Indian children with Kawasaki disease[J]. Rheumatol Int，2016，36（4）:551
[29] Satoh K，Wakejima Y，Gau M，et al. Risk of coronary artery lesions in young infants with Kawasaki disease：need for a new diagnostic method[J]. Int J Rheum Dis，2018，21（3）:746
[30] 张帆.血清Nt-proBNP在小儿川崎病中的浓度变化研究分析[J].吉林医学，2019，40（6）:1237

相似文献/References:

[1]王晓晓,周宇辉,王倩,等.氨基末端脑钠肽前体水平对丙种球蛋白无反应性川崎病的预测价值[J].天津医科大学学报,2016,22(06):502.
　WANG Xiao-xiao,ZHOU Yu-hui,WANG Qian,et al.Predictive value of plasma brain natriuretic peptide in IVIG-resistant Kawasaki disease[J].Journal of Tianjin Medical University,2016,22(02):502.
[2]王茜,周宇辉,王雨婷,等.川崎病并发冠状动脉损害危险因素的探讨[J].天津医科大学学报,2020,26(01):56.
　WANG Xi,ZHOU Yu-hui,WANG Yu-ting,et al.Risk factors of complicated coronary artery lesion in Kawasaki disease[J].Journal of Tianjin Medical University,2020,26(02):56.
[3]贾丽娟,吕爱婷,冯迎军,等.KD患儿急性期h-FABP、PAC-1表达与冠状动脉受损的关系[J].天津医科大学学报,2021,27(04):334.
　JIA Li-juan,Lyu Ai-ting,FENG Ying-jun,et al.Relationship between expression of h-FABP and PAC-1 and coronary artery damage in children with KD in acute phase[J].Journal of Tianjin Medical University,2021,27(02):334.

[1]韩飞综述,刘力审校.血清Ｎ末端Ｂ型利钠肽在识别川崎病冠状动脉损伤中的研究进展[J].天津医科大学学报,2021,27(02):208.

点击复制

血清Ｎ末端Ｂ型利钠肽在识别川崎病冠状动脉损伤中的研究进展(PDF)

分享到：

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

文章信息/Info

参考文献/References:

相似文献/References:

备注/Memo

常用功能

导航/Navigate

工具/Tools

统计/Statistics